Pharma and life sciences
Product, location and partner data that traces end to end.
Traceability rules require every trading partner to exchange product and transaction data electronically, and every exchange depends on product, location and partner records that agree. We fix that data foundation, and the healthcare professional data commercial teams rely on.
Book a scoping call
01 / Symptoms
What it looks like.
- Trading partner and location identifiers that differ between systems.
- Product records that disagree across ERP, serialization and commercial systems.
- Healthcare professional records duplicated across CRM and spend reporting.
02 / Where it breaks
Where it breaks, area by area.
03 / Why now
Why this year.
Nov 27, 2026
The FDA's exemption from DSCSA's enhanced requirements for small dispensers ends November 27, 2026, after which electronic, interoperable tracing applies to all dispensers.
Source: Freyr (opens in a new tab)Exceptions in data exchange land on the manufacturer's and distributor's desk, whoever caused them.
05 / Experience
Product, location, supplier and customer masters are our core domains. We apply them to pharma's identifiers and partner rules.
Questions
Our serialization vendor handles DSCSA.
It moves the data. Whether the product, location and partner records behind it agree is a master data question.